128 related articles for article (PubMed ID: 34606672)
1. Values of serum CA125, NSE and 24-hour urine VMA in diagnosis and prediction of treatment of paediatric neuroblastoma.
Li J; Liu X; Chen M; Wang J; Wang X
Int J Clin Pract; 2021 Dec; 75(12):e14932. PubMed ID: 34606672
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma.
Li J; Qi Z; Chen M; Wang J; Liu X
Ital J Pediatr; 2023 Aug; 49(1):102. PubMed ID: 37620978
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
4. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
5. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
[TBL] [Abstract][Full Text] [Related]
6. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
Sun Q; Chen Y; Jin Q; Yuan X
Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
[TBL] [Abstract][Full Text] [Related]
7. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
Sadilkova K; Dugaw K; Benjamin D; Jack RM
Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
[TBL] [Abstract][Full Text] [Related]
8. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
9. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
10. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
11. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
12. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
Tsuchida Y; Honna T; Iwanaka T; Saeki M; Taguchi N; Kaneko T; Koide R; Tsunematsu Y; Shimizu K; Makino S
J Pediatr Surg; 1987 May; 22(5):419-24. PubMed ID: 3585664
[TBL] [Abstract][Full Text] [Related]
13. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
[TBL] [Abstract][Full Text] [Related]
14. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
[TBL] [Abstract][Full Text] [Related]
16. Vanilmandelic acid and homovanillic acid levels in patients with neural crest tumor: 24-hour urine collection versus random sample.
Gregianin LJ; McGill AC; Pinheiro CM; Brunetto AL
Pediatr Hematol Oncol; 1997; 14(3):259-65. PubMed ID: 9185210
[TBL] [Abstract][Full Text] [Related]
17. Screening procedures for neuroblastoma: false-negative results.
Johnsonbaugh RE; Cahill R
Pediatrics; 1975 Aug; 56(2):267-70. PubMed ID: 1161374
[TBL] [Abstract][Full Text] [Related]
18. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
Hashimoto K; Gotoh Y; Tada K
Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
[TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase in children's cancer.
Cooper EH; Pritchard J; Bailey CC; Ninane J
Br J Cancer; 1987 Jul; 56(1):65-7. PubMed ID: 3476145
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
